Stockscreener 앱 받기
0.7904
0.33%
-0.0026
시간 외 거래:
1.96
1.1696
+147.98%
전일 마감가:
$0.793
열려 있는:
$0.788
하루 거래량:
59,230
Relative Volume:
0.20
시가총액:
$39.94M
수익:
$8.72M
순이익/손실:
$-6.83M
주가수익비율:
-4.7932
EPS:
-0.1649
순현금흐름:
$-6.27M
1주 성능:
+0.05%
1개월 성능:
-3.61%
6개월 성능:
-11.62%
1년 성능:
-12.09%
1일 변동 폭
$0.7869
$0.82
1주일 범위
$0.75
$0.905
52주 변동 폭
$0.3954
$1.16
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.20 | 2.68B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.87 | 345.29M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.16 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.84 | 389.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
44.90 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time - Yahoo Finance
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
JonesTrading Begins Coverage on NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuroone medical chief business officer buys $670k in NMTC By Investing.com - Investing.com South Africa
Neuroone medical chief business officer buys $670k in NMTC - Investing.com
NeuroOne Medical Technologies Officer Acquires 1 Million Shares - TradingView
NEUROONE (NASDAQ: NMTC) CBO buys 1M shares and receives 500K options - Stock Titan
NeuroOne (NMTC) Chief Business Officer files initial Form 3 insider report - Stock Titan
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares - Yahoo Finance
Neuroone Medical stock initiated at Buy by Jones Trading - Investing.com Canada
Jones Trading Initiates Coverage on NMTC with Buy Rating and $1. - GuruFocus
NMTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeuroOne (NMTC) schedules 2026 shareholder meeting and Rule 14a-8 cutoff - Stock Titan
Aug Final Week: What dividend growth rate does NeuroOne Medical Technologies Corporation offerJuly 2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Wall Street Zen Upgrades NeuroOne Medical Technologies (NASDAQ:NMTC) to Sell - Defense World
NeuroOne Medical Technologies Q1 Earnings Call Highlights - Defense World
NeuroOne Earnings Call Balances Growth With Cash Strain - TipRanks
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call - GuruFocus
Earnings call transcript: NeuroOne Medical beats Q1 2026 EPS forecast, stock dips - Investing.com Nigeria
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript - The Globe and Mail
NeuroOne Reports Fiscal Q1 2026 Financial Results - TradingView
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
What to Expect from NeuroOne Medical Tech's Earnings - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything Yo - GuruFocus
NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update - 富途牛牛
Minne InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time - The Globe and Mail
Inside NeuroOne's brain electrode technology - MobiHealthNews
NeuroOne electrodes target motor issues and pain - MobiHealthNews
How NeuroOne's minimally invasive brain technology works - Healthcare IT News
Will NeuroOne Medical Technologies Corporation stock outperform tech sector in 2025Market Performance Recap & Verified Short-Term Trading Plans - Улправда
Will NeuroOne Medical Technologies Corporation stock deliver better than expected guidance2025 Key Lessons & Growth Focused Entry Point Reports - Улправда
Will NeuroOne Medical Technologies Corporation stock see insider buying2025 Earnings Surprises & Low Risk High Reward Ideas - Улправда
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
New Strong Buy Stocks for January 6th - Yahoo Finance
NeuroOne Medical Technologies Q4 Earnings Call Highlights - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
NeuroOne appoints Penumbra executive Jason Mills to board - Investing.com
NeuroOne(R) Appoints Jason Mills to the Board of Directors - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock in correction or buying zoneWeekly Trade Analysis & Technical Confirmation Trade Alerts - Улправда
Will NeuroOne Medical Technologies Corporation stock benefit from upcoming earnings reportsTrade Entry Report & Low Risk High Win Rate Stock Picks - ulpravda.ru
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... By GuruFocus - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock attractive for hedge fundsJuly 2025 Momentum & High Return Stock Watch Alerts - Улправда
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises - Investing.com
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results - TradingView — Track All Markets
NeuroOne Medical Technologies (NASDAQ: NMTC) details FY 2025 results release - Stock Titan
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.21%
0.24%
자본화:
|
볼륨(24시간):